Department of Anatomy and Cell Biology, University of Western Ontario, London, ON N6A 5C1, Canada.
Department of Physiology and Pharmacology, University of Western Ontario, London, ON N6A 5C1, Canada.
Int J Mol Sci. 2022 Jan 1;23(1):486. doi: 10.3390/ijms23010486.
Although inherited (encoding Cx43) gene mutations most often lead to oculodentodigital dysplasia and related disorders, four variants have been linked to erythrokeratodermia variabilis et progressiva (EKVP), a skin disorder characterized by erythematous and hyperkeratotic lesions. While two autosomal-dominant EKVP-linked mutations have been shown to lead to augmented hemichannels, the consequence(s) of keratinocytes harboring a de novo P283L variant alone or in combination with a de novo T290N variant remain unknown. Interestingly, these variants reside within or adjacent to a carboxy terminus polypeptide motif that has been shown to be important in regulating the internalization and degradation of Cx43. Cx43-rich rat epidermal keratinocytes (REKs) or Cx43-ablated REKs engineered to express fluorescent protein-tagged P283L and/or T290N variants formed prototypical gap junctions at cell-cell interfaces similar to wildtype Cx43. Dye coupling and dye uptake studies further revealed that each variant or a combination of both variants formed functional gap junction channels, with no evidence of augmented hemichannel function or induction of cell death. Tracking the fate of EKVP-associated variants in the presence of the protein secretion blocker brefeldin A, or an inhibitor of protein synthesis cycloheximide, revealed that P283L or the combination of P283L and T290N variants either significantly extended Cx43 residency on the cell surface of keratinocytes or delayed its degradation. However, caution is needed in concluding that this modest change in the Cx43 life cycle is sufficient to cause EKVP, or whether an additional underlying mechanism or another unidentified gene mutation is contributing to the pathogenesis found in patients. This question will be resolved if further patients are identified where whole exome sequencing reveals a Cx43 P283L variant alone or, in combination with a T290N variant, co-segregates with EKVP across several family generations.
虽然遗传性 (编码 Cx43) 基因突变最常导致眼 - 牙 - 指发育不良和相关疾病,但有四个变体与红细胞角质层病变伴进行性变化 (EKVP) 相关联,这是一种以红斑和角化过度病变为特征的皮肤疾病。虽然已经表明两种常染色体显性 EKVP 相关突变会导致半通道增强,但单独或与从头 T290N 变体组合携带从头 P283L 变体的角质细胞的后果仍然未知。有趣的是,这些变体位于羧基末端多肽基序内或附近,该基序已被证明在调节 Cx43 的内化和降解中很重要。富含 Cx43 的大鼠表皮角质细胞 (REKs) 或表达荧光蛋白标记的 P283L 和/或 T290N 变体的 Cx43 缺失的 REKs 在细胞 - 细胞界面形成典型的间隙连接,类似于野生型 Cx43。染料偶联和染料摄取研究进一步表明,每个变体或两者的组合形成功能性间隙连接通道,没有证据表明半通道功能增强或诱导细胞死亡。在存在蛋白分泌抑制剂布雷非德菌素 A 或蛋白合成抑制剂环己酰亚胺的情况下跟踪 EKVP 相关变体的命运,发现 P283L 或 P283L 和 T290N 变体的组合要么显著延长 Cx43 在角质细胞表面的驻留时间,要么延迟其降解。然而,在得出结论认为 Cx43 生命周期中的这种微小变化足以导致 EKVP 时,或者是否存在另一种潜在的机制或另一个未识别的基因突变导致患者中发现的发病机制时,需要谨慎。如果进一步的患者被确定,并且外显子组测序显示 Cx43 P283L 变体单独或与 T290N 变体组合与 EKVP 在多个家族世代中共同分离,则可以解决这个问题。